- Filed
- Apr 9, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Apr 7, 2026 | 37.82M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 9.25M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 3.09M sh |
| Capex | FY 2025 · Dec 31, 2025 | $31K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$6.2M |
| Operating Cash Flow restated | FY 2025 · Dec 31, 2024 | −$340K |
| Short Term Debt | FY 2025 · Dec 31, 2025 | $12K |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $2.63M |
| Cash And Equivalents restated | FY 2025 · Dec 31, 2024 | $6.9M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | −$19.79M |
| Stockholders Equity restated | FY 2025 · Dec 31, 2024 | −$163.35M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $43.55M |
| Current Liabilities restated | FY 2025 · Dec 31, 2024 | $171.45M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $45.19M |
| Total Liabilities restated | FY 2025 · Dec 31, 2024 | $172.46M |
| Current Assets | FY 2025 · Dec 31, 2025 | $13.56M |
| Current Assets restated | FY 2025 · Dec 31, 2024 | $9.09M |
| Total Assets | FY 2025 · Dec 31, 2025 | $202.39M |
| Total Assets restated | FY 2025 · Dec 31, 2024 | $9.11M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | $7.96 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$51.96 |
| Eps Diluted | FY 2025 · Sep 30, 2024 | −$4.93 |
| Eps Basic | FY 2025 · Dec 31, 2025 | $8.45 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$51.96 |
| Eps Basic | FY 2025 · Sep 30, 2024 | −$4.93 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $28.08M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $4.53M |
| Sga Expense | FY 2025 · Sep 30, 2024 | $6.71M |
| Net Income | FY 2025 · Dec 31, 2025 | $78.55M |
| Net Income restated | FY 2025 · Dec 31, 2024 | −$160.79M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$32.6M |
| Operating Income restated | FY 2025 · Dec 31, 2024 | −$4.53M |